Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.
DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.
Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.
ThirtyFiveBio is a biotech company developing a gut epithelial shield for patients with colitis
Starday Foods is a healthy and sustainable food products company.
Cephagenix focuses on identifying and developing new, effective migraine therapies.
Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.
Soufflé Therapeutics has potent, precise, and safe medicines can be designed and developed for all diseases.
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Accent Therapeutics is a biopharmaceutical company.
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.
Capsida Biotherapeutics is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.
Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.
Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).
Stemson Therapeutics is a pre-clinical stage cell therapy company.
Faze Medicines is a biotechnology company.
Rheostat Therapeutics is a bio therapeutics company.
Palleon Pharmaceuticals is a developer of a biotechnology platform designed to offer glycoimmune checkpoint inhibitors to treat cancer.
AbbVie has invested in 57 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
AbbVie's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 16 different industry categories.
Among tracked funding rounds, Morphic Therapeutic received $276.0M in a Post Ipo Equity round. AbbVie's total known invested capital is $2.5B.
AbbVie's average investment size is $57.5M across its portfolio of 57 companies.
Recent AbbVie portfolio additions include Alector, Zag Bio, DISCO Pharmaceuticals, Artios Pharma, Syndeio Biosciences. These companies were founded in 2020 or later.